Biomus 0.5 mg Capsule
Request Pricing & Availability
Fill in your details below and our clinical team will get back to you with pricing & availability within 24 hours.
Similar Products
About our medical review process
Dr. Sophie Reynolds Dr. Sophie Reynolds is a board-certified medical doctor specializing in internal medicine. With over a decade of experience in patient care and medical writing
Description
Biomus 0.5mg Tacrolimus capsule are manufactured by Alniche Life Sciences in India and contain 0.5mg of Tacrolimus per capsule. Each Blister pack includes 10 Tablets , making Biomus 0.5mg Tacrolimus capsule an effective option for Kidney . Prescription Required from your healthcare provider to purchase Tacrolimus medicine. Indogenmed deals in all type of generic Tacrolimus medicine.
Related Products
-
Cyclopure 100 mg Capsule
CyclosporinePrice on request
Request pricing -
LuciBelu 200 mg Tablet
BelumosudilPrice on request
Request pricing -
Biomus 0.25 mg Capsule
TacrolimusPrice on request
Request pricing -
Biomus 2 mg Capsule
TacrolimusPrice on request
Request pricing -
Biomus 1 mg Capsule
TacrolimusPrice on request
Request pricing -
Biomyf S Tablet
Mycophenolate MofetilPrice on request
Request pricing -
Biomyf 500 mg Tablet
Mycophenolate MofetilPrice on request
Request pricing -
Mofilet 500 mg Tablet
Price on request
Request pricing -
Mofilet 250 mg Tablet
Price on request
Request pricing -
Cyclophil Me 100 mg Capsule
CyclosporinePrice on request
Request pricing -
Rapasim 1 mg Tablet
Price on request
Request pricing -
Raparen 1 mg Injection
Price on request
Request pricing
Shipping & Delivery
- Ships from
- India, worldwide delivery
- Order processing
- 1–3 business days after checks
- Transit time
- 5–7 business days by express courier
- Tracking
- Tracking number sent by email or SMS
- Packaging
- Discreet, tamper-evident, cold-chain available
- Duties & taxes
- Payable by the recipient on import
Only logged in customers who have purchased this product may leave a review.
Reviews
Clear filtersThere are no reviews yet.